A key objective in recent years has been to establish a growing profitable specialty pharmaceutical company, with its own commercial capabilities to bring new products to market. As we have reached profitability, maximizing the potential of our Zubsolv® business continues to be a key objective, and is the enabler of increased investments in R&D and business development, with a focus on addiction.